Description

This issue of Vital Signs, released on September 28, 2009, provides a strategic overview of recent trends and activities in embryonic stem cell therapy research. Additionally, a company spotlight is provided for KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on developing aesthetic medications. Reimbursement and regulatory news from the FDA is also provided for the week of September 14, 2009.